| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dinucleotide insertion or deletion binding | 3.73e-05 | 3 | 71 | 2 | GO:0032139 | |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 9.37e-05 | 25 | 71 | 3 | GO:0034237 | |
| GeneOntologyMolecularFunction | DNA insertion or deletion binding | 1.85e-04 | 6 | 71 | 2 | GO:0032135 | |
| GeneOntologyMolecularFunction | MutLalpha complex binding | 2.59e-04 | 7 | 71 | 2 | GO:0032405 | |
| GeneOntologyMolecularFunction | mismatch repair complex binding | 6.72e-04 | 11 | 71 | 2 | GO:0032404 | |
| GeneOntologyMolecularFunction | mismatched DNA binding | 1.10e-03 | 14 | 71 | 2 | GO:0030983 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 1.10e-03 | 14 | 71 | 2 | GO:0070679 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 1.16e-03 | 58 | 71 | 3 | GO:0051018 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.16e-03 | 129 | 71 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.30e-03 | 749 | 71 | 9 | GO:0005509 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.36e-03 | 230 | 71 | 5 | GO:0005516 | |
| GeneOntologyMolecularFunction | protein kinase A catalytic subunit binding | 1.45e-03 | 16 | 71 | 2 | GO:0034236 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.84e-03 | 18 | 71 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.06e-03 | 151 | 71 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 2.08e-03 | 372 | 71 | 6 | GO:0061630 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 8.85e-06 | 217 | 70 | 7 | GO:0097553 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 1.02e-05 | 146 | 70 | 6 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 1.07e-05 | 147 | 70 | 6 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 1.15e-05 | 149 | 70 | 6 | GO:0051282 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 1.34e-05 | 153 | 70 | 6 | GO:0051208 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 2.87e-05 | 359 | 70 | 8 | GO:0006874 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 5.07e-05 | 389 | 70 | 8 | GO:0055074 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol catabolic process | 6.78e-05 | 4 | 70 | 2 | GO:0031161 | |
| GeneOntologyCellularComponent | Z disc | 1.53e-04 | 151 | 70 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | sarcomere | 1.86e-04 | 249 | 70 | 6 | GO:0030017 | |
| GeneOntologyCellularComponent | I band | 2.37e-04 | 166 | 70 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | myofibril | 3.06e-04 | 273 | 70 | 6 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 4.22e-04 | 290 | 70 | 6 | GO:0043292 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 4.61e-04 | 45 | 70 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 4.89e-04 | 10 | 70 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | supramolecular fiber | CASP14 PDLIM3 EFCAB6 PPP1R12B TRPC1 DNAH17 TRIM54 CFAP206 MACF1 NEXN MEFV RYR2 | 4.99e-04 | 1179 | 70 | 12 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CASP14 PDLIM3 EFCAB6 PPP1R12B TRPC1 DNAH17 TRIM54 CFAP206 MACF1 NEXN MEFV RYR2 | 5.31e-04 | 1187 | 70 | 12 | GO:0099081 |
| GeneOntologyCellularComponent | cation channel complex | 1.15e-03 | 235 | 70 | 5 | GO:0034703 | |
| Domain | PLC-beta_C | 4.03e-05 | 3 | 69 | 2 | IPR014815 | |
| Domain | PLC-beta_CS | 4.03e-05 | 3 | 69 | 2 | IPR009535 | |
| Domain | DUF1154 | 4.03e-05 | 3 | 69 | 2 | PF06631 | |
| Domain | PLC-beta_C | 4.03e-05 | 3 | 69 | 2 | PF08703 | |
| Domain | PLC-beta | 8.03e-05 | 4 | 69 | 2 | IPR016280 | |
| Domain | RIH_assoc | 2.00e-04 | 6 | 69 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 2.00e-04 | 6 | 69 | 2 | IPR013662 | |
| Domain | RIH_dom | 2.00e-04 | 6 | 69 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 2.00e-04 | 6 | 69 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.00e-04 | 6 | 69 | 2 | IPR015925 | |
| Domain | - | 2.00e-04 | 6 | 69 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 2.00e-04 | 6 | 69 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 2.00e-04 | 6 | 69 | 2 | PF08709 | |
| Domain | ARM-type_fold | 2.51e-04 | 339 | 69 | 7 | IPR016024 | |
| Domain | Znf_C3HC4_RING-type | 4.36e-04 | 172 | 69 | 5 | IPR018957 | |
| Domain | MIR | 5.94e-04 | 10 | 69 | 2 | PS50919 | |
| Domain | MIR | 5.94e-04 | 10 | 69 | 2 | PF02815 | |
| Domain | MIR | 5.94e-04 | 10 | 69 | 2 | SM00472 | |
| Domain | MIR_motif | 5.94e-04 | 10 | 69 | 2 | IPR016093 | |
| Domain | Ion_trans_dom | 8.39e-04 | 114 | 69 | 4 | IPR005821 | |
| Domain | Ion_trans | 8.39e-04 | 114 | 69 | 4 | PF00520 | |
| Domain | PLipase_C_Pinositol-sp_Y | 1.37e-03 | 15 | 69 | 2 | IPR001711 | |
| Domain | EF-hand_like | 1.37e-03 | 15 | 69 | 2 | PF09279 | |
| Domain | PIPLC_Y_DOMAIN | 1.37e-03 | 15 | 69 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 1.37e-03 | 15 | 69 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 1.37e-03 | 15 | 69 | 2 | IPR015359 | |
| Domain | PI-PLC-Y | 1.37e-03 | 15 | 69 | 2 | PF00387 | |
| Domain | PLCYc | 1.37e-03 | 15 | 69 | 2 | SM00149 | |
| Domain | zf-C3HC4 | 1.40e-03 | 223 | 69 | 5 | PF00097 | |
| Domain | C2 | 1.40e-03 | 131 | 69 | 4 | PF00168 | |
| Domain | C2 | 1.66e-03 | 137 | 69 | 4 | SM00239 | |
| Domain | C2 | 1.89e-03 | 142 | 69 | 4 | PS50004 | |
| Domain | PI-PLC-X | 1.98e-03 | 18 | 69 | 2 | PF00388 | |
| Domain | PLCXc | 1.98e-03 | 18 | 69 | 2 | SM00148 | |
| Domain | BBOX | 2.12e-03 | 69 | 69 | 3 | SM00336 | |
| Domain | - | 2.20e-03 | 148 | 69 | 4 | 2.60.40.150 | |
| Domain | PIPLC_X_DOMAIN | 2.21e-03 | 19 | 69 | 2 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 2.21e-03 | 19 | 69 | 2 | IPR000909 | |
| Domain | - | 2.30e-03 | 71 | 69 | 3 | 4.10.45.10 | |
| Domain | zf-B_box | 2.40e-03 | 72 | 69 | 3 | PF00643 | |
| Domain | - | 2.78e-03 | 261 | 69 | 5 | 1.10.238.10 | |
| Domain | Znf_RING_CS | 3.11e-03 | 163 | 69 | 4 | IPR017907 | |
| Domain | C2_dom | 3.18e-03 | 164 | 69 | 4 | IPR000008 | |
| Domain | ZF_BBOX | 3.24e-03 | 80 | 69 | 3 | PS50119 | |
| Domain | Znf_B-box | 3.35e-03 | 81 | 69 | 3 | IPR000315 | |
| Domain | - | 3.82e-03 | 25 | 69 | 2 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 3.82e-03 | 25 | 69 | 2 | IPR017946 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 6.26e-06 | 10 | 54 | 3 | M47661 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 8.58e-06 | 11 | 54 | 3 | M49033 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.48e-05 | 13 | 54 | 3 | M39589 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.48e-05 | 13 | 54 | 3 | M47656 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 5.78e-05 | 20 | 54 | 3 | M47688 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 5.82e-05 | 178 | 54 | 6 | M2890 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 6.73e-05 | 21 | 54 | 3 | M47689 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 7.77e-05 | 22 | 54 | 3 | M39795 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 7.77e-05 | 22 | 54 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 7.77e-05 | 22 | 54 | 3 | M47675 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 8.54e-05 | 61 | 54 | 4 | MM15071 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.91e-05 | 23 | 54 | 3 | M47676 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 1.46e-04 | 70 | 54 | 4 | M8232 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.63e-04 | 72 | 54 | 4 | MM14631 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 2.14e-04 | 6 | 54 | 2 | M47548 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 2.22e-04 | 78 | 54 | 4 | M1921 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.41e-04 | 147 | 54 | 5 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.73e-04 | 151 | 54 | 5 | M39329 | |
| Pathway | PID_IL8_CXCR2_PATHWAY | 2.92e-04 | 34 | 54 | 3 | M210 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY | 2.99e-04 | 7 | 54 | 2 | M47505 | |
| Pathway | REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION | 3.97e-04 | 8 | 54 | 2 | MM15032 | |
| Pathway | REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION | 3.97e-04 | 8 | 54 | 2 | M27356 | |
| Pathway | REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION | 3.97e-04 | 8 | 54 | 2 | MM15100 | |
| Pathway | WP_MISMATCH_REPAIR | 5.10e-04 | 9 | 54 | 2 | MM15932 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY | 6.35e-04 | 10 | 54 | 2 | M47644 | |
| Pathway | REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION | 6.35e-04 | 10 | 54 | 2 | M1825 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 7.67e-04 | 108 | 54 | 4 | M17034 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 7.75e-04 | 11 | 54 | 2 | M27317 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 7.75e-04 | 11 | 54 | 2 | MM15035 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY | 7.75e-04 | 11 | 54 | 2 | M47637 | |
| Pathway | BIOCARTA_MYOSIN_PATHWAY | 7.75e-04 | 11 | 54 | 2 | M7014 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 7.75e-04 | 11 | 54 | 2 | M47958 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 8.14e-04 | 48 | 54 | 3 | M26964 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 8.14e-04 | 48 | 54 | 3 | MM14589 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 9.17e-04 | 50 | 54 | 3 | M47951 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY | 9.27e-04 | 12 | 54 | 2 | M47649 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY | 9.27e-04 | 12 | 54 | 2 | M47628 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 9.71e-04 | 115 | 54 | 4 | M9387 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.15e-03 | 54 | 54 | 3 | M26911 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.15e-03 | 54 | 54 | 3 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.15e-03 | 54 | 54 | 3 | MM15202 | |
| Pathway | WP_GPR40_PATHWAY | 1.46e-03 | 15 | 54 | 2 | M39526 | |
| Pathway | REACTOME_MISMATCH_REPAIR | 1.46e-03 | 15 | 54 | 2 | M27442 | |
| Pathway | REACTOME_MISMATCH_REPAIR | 1.46e-03 | 15 | 54 | 2 | MM15184 | |
| Pathway | REACTOME_CA2_PATHWAY | 1.71e-03 | 62 | 54 | 3 | M27321 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.12e-03 | 18 | 54 | 2 | M47659 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 2.34e-03 | 146 | 54 | 4 | M27288 | |
| Pathway | BIOCARTA_CCR3_PATHWAY | 2.36e-03 | 19 | 54 | 2 | MM1361 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY | 2.36e-03 | 19 | 54 | 2 | M47596 | |
| Pathway | BIOCARTA_PAR1_PATHWAY | 2.36e-03 | 19 | 54 | 2 | MM1514 | |
| Pathway | BIOCARTA_PAR1_PATHWAY | 2.36e-03 | 19 | 54 | 2 | M3494 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.36e-03 | 19 | 54 | 2 | M47760 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 2.36e-03 | 19 | 54 | 2 | M47543 | |
| Pathway | BIOCARTA_CCR3_PATHWAY | 2.36e-03 | 19 | 54 | 2 | M9152 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 2.43e-03 | 70 | 54 | 3 | M3115 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 2.84e-03 | 74 | 54 | 3 | MM15962 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY | 2.89e-03 | 21 | 54 | 2 | M47638 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 2.89e-03 | 21 | 54 | 2 | M27409 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 2.89e-03 | 21 | 54 | 2 | MM15159 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 2.89e-03 | 21 | 54 | 2 | M47542 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 2.95e-03 | 75 | 54 | 3 | M39568 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 3.07e-03 | 76 | 54 | 3 | M9052 | |
| Pathway | KEGG_MISMATCH_REPAIR | 3.46e-03 | 23 | 54 | 2 | M13515 | |
| Pathway | WP_DNA_MISMATCH_REPAIR | 3.46e-03 | 23 | 54 | 2 | M39668 | |
| Pubmed | DOCK2 XRN2 SERPINB9 CCDC47 NBEAL2 WWP2 ICAM2 GNL2 CD58 PSMC2 MSH2 DHX9 ITPR2 | 6.16e-07 | 1168 | 71 | 13 | 19946888 | |
| Pubmed | 6.79e-07 | 9 | 71 | 3 | 15623527 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | WBP11 XRN2 CASP14 LARS1 GNL2 MACF1 MSH2 SF3B2 PCNA MYO5C DHX9 ITPR2 | 1.03e-06 | 1024 | 71 | 12 | 24711643 |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.12e-06 | 38 | 71 | 4 | 30786075 | |
| Pubmed | Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. | 3.64e-06 | 15 | 71 | 3 | 28578927 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 28158491 | ||
| Pubmed | Ins(1,4,5)P(3) regulates phospholipase Cbeta1 expression in cardiomyocytes. | 4.11e-06 | 2 | 71 | 2 | 18692062 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 11336651 | ||
| Pubmed | Overexpression of Bmi‑1 promotes epithelial‑mesenchymal transition in CD133+Hep G2 cells. | 4.11e-06 | 2 | 71 | 2 | 28849237 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 18249094 | ||
| Pubmed | Mitochondrial calcium overload is a key determinant in heart failure. | 4.11e-06 | 2 | 71 | 2 | 26217001 | |
| Pubmed | CD133 and BMI1 expressions and its prognostic role in primary glioblastoma. | 4.11e-06 | 2 | 71 | 2 | 26690524 | |
| Pubmed | Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis. | 4.11e-06 | 2 | 71 | 2 | 8858149 | |
| Pubmed | Bmi-1 is essential for the oncogenic potential in CD133(+) human laryngeal cancer cells. | 4.11e-06 | 2 | 71 | 2 | 26081615 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 11352932 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 10970773 | ||
| Pubmed | FBXO38 WBP11 CCDC47 PTPRZ1 TBC1D5 PPP1R12B GNL2 PSMC2 MSH2 TRIM13 ITPR2 | 8.73e-06 | 1049 | 71 | 11 | 27880917 | |
| Pubmed | 1.06e-05 | 21 | 71 | 3 | 30270038 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 8687404 | ||
| Pubmed | The MutSalpha-proliferating cell nuclear antigen interaction in human DNA mismatch repair. | 1.23e-05 | 3 | 71 | 2 | 18326858 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 15849733 | ||
| Pubmed | Molecular portraits of heterogeneity related to cancer stem cells in human ovarian cancer. | 1.23e-05 | 3 | 71 | 2 | 24300467 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | XRN2 CCDC47 LARS1 GNL2 PSMC2 PUM2 MSH2 PPIP5K2 SF3B2 PCNA EIF3CL DHX9 | 1.35e-05 | 1318 | 71 | 12 | 30463901 |
| Pubmed | 1.60e-05 | 24 | 71 | 3 | 10843712 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 1.75e-05 | 922 | 71 | 10 | 27609421 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | XRN2 CASP14 CCDC47 MCM3AP LARS1 PSMC2 MACF1 MSH2 NEXN SF3B2 PCNA DHX9 | 1.75e-05 | 1353 | 71 | 12 | 29467282 |
| Pubmed | 1.81e-05 | 733 | 71 | 9 | 34672954 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 9753089 | ||
| Pubmed | Abnormal taste perception in mice lacking the type 3 inositol 1,4,5-trisphosphate receptor. | 2.46e-05 | 4 | 71 | 2 | 17925404 | |
| Pubmed | Dependence of nucleotide substitutions on Ung2, Msh2, and PCNA-Ub during somatic hypermutation. | 2.46e-05 | 4 | 71 | 2 | 19901081 | |
| Pubmed | Phospholipase C-β1 potentiates glucose-stimulated insulin secretion. | 2.46e-05 | 4 | 71 | 2 | 31268747 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 24141788 | ||
| Pubmed | G-protein-activated phospholipase C-beta, new partners for cell polarity proteins Par3 and Par6. | 2.46e-05 | 4 | 71 | 2 | 15782111 | |
| Pubmed | Nuclear reorganization of DNA mismatch repair proteins in response to DNA damage. | 2.46e-05 | 4 | 71 | 2 | 20004149 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 9188725 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 21855803 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 23006664 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 19120137 | ||
| Pubmed | SERCA2b and 3 play a regulatory role in store-operated calcium entry in human platelets. | 2.46e-05 | 4 | 71 | 2 | 18068335 | |
| Pubmed | Phospholipase C isozymes selectively couple to specific neurotransmitter receptors. | 2.46e-05 | 4 | 71 | 2 | 9305844 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 15174099 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | WBP11 INTS7 CCDC47 LARS1 GNL2 PSMC2 MACF1 PLCB3 MSH2 SF3B2 PCNA DHX9 | 2.72e-05 | 1415 | 71 | 12 | 28515276 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.78e-05 | 774 | 71 | 9 | 15302935 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 3.38e-05 | 179 | 71 | 5 | 36261009 | |
| Pubmed | 3.52e-05 | 31 | 71 | 3 | 12171929 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 15611108 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 21725088 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 14676842 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 11941371 | ||
| Pubmed | 4.26e-05 | 33 | 71 | 3 | 19714462 | ||
| Pubmed | Genetic mapping of the human and mouse phospholipase C genes. | 4.26e-05 | 33 | 71 | 3 | 8672127 | |
| Pubmed | 4.66e-05 | 34 | 71 | 3 | 20301725 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 4.78e-05 | 639 | 71 | 8 | 23443559 | |
| Pubmed | 4.79e-05 | 97 | 71 | 4 | 25071155 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 5.31e-05 | 475 | 71 | 7 | 31040226 | |
| Pubmed | 5.68e-05 | 655 | 71 | 8 | 35819319 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 8739298 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 23463619 | ||
| Pubmed | Isolation and characterization of spheroid cells from human malignant melanoma cell line WM-266-4. | 6.13e-05 | 6 | 71 | 2 | 19940551 | |
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 23540699 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 6.13e-05 | 6 | 71 | 2 | 25966694 | |
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 2841328 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 6.13e-05 | 6 | 71 | 2 | 16844763 | |
| Pubmed | 7.63e-05 | 40 | 71 | 3 | 16210410 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 12821674 | ||
| Pubmed | A defined human system that supports bidirectional mismatch-provoked excision. | 8.57e-05 | 7 | 71 | 2 | 15225546 | |
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 11860456 | ||
| Pubmed | Genetic dissection of gustatory sensitivity to bitterness (sucrose octaacetate) in mice. | 8.57e-05 | 7 | 71 | 2 | 10609087 | |
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 14757526 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 9.10e-05 | 701 | 71 | 8 | 30196744 | |
| Pubmed | 9.61e-05 | 116 | 71 | 4 | 21549307 | ||
| Pubmed | 9.97e-05 | 225 | 71 | 5 | 12168954 | ||
| Pubmed | CACNA1A PJA2 SYT11 KCNJ3 PLCB1 PSMC2 MACF1 ZDBF2 RYR2 EIF3CL | 1.03e-04 | 1139 | 71 | 10 | 36417873 | |
| Pubmed | 1.13e-04 | 723 | 71 | 8 | 34133714 | ||
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 1.13e-04 | 231 | 71 | 5 | 36597993 | |
| Pubmed | 1.13e-04 | 121 | 71 | 4 | 22412018 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 9651375 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.14e-04 | 8 | 71 | 2 | 19033399 | |
| Pubmed | 1.15e-04 | 538 | 71 | 7 | 28524877 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.17e-04 | 934 | 71 | 9 | 33916271 | |
| Pubmed | 1.20e-04 | 234 | 71 | 5 | 36243803 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 1.32e-04 | 949 | 71 | 9 | 36574265 | |
| Pubmed | 1.47e-04 | 9 | 71 | 2 | 7589147 | ||
| Pubmed | Praja1, a novel gene encoding a RING-H2 motif in mouse development. | 1.47e-04 | 9 | 71 | 2 | 9393880 | |
| Pubmed | The SNF2-like helicase HELLS mediates E2F3-dependent transcription and cellular transformation. | 1.47e-04 | 9 | 71 | 2 | 22157815 | |
| Pubmed | 1.47e-04 | 9 | 71 | 2 | 11254741 | ||
| Pubmed | Identification of DNA replication and cell cycle proteins that interact with PCNA. | 1.47e-04 | 9 | 71 | 2 | 9396813 | |
| Pubmed | 1.47e-04 | 9 | 71 | 2 | 10501179 | ||
| Pubmed | Feedback regulation of transcriptional termination by the mammalian circadian clock PERIOD complex. | 1.47e-04 | 9 | 71 | 2 | 22767893 | |
| Pubmed | Expression of phospholipase C isozymes by murine B lymphocytes. | 1.83e-04 | 10 | 71 | 2 | 2033248 | |
| Pubmed | 1.83e-04 | 10 | 71 | 2 | 23295235 | ||
| Pubmed | The mammalian TRIM-NHL protein TRIM71/LIN-41 is a repressor of mRNA function. | 1.83e-04 | 10 | 71 | 2 | 23125361 | |
| Pubmed | 1.87e-04 | 407 | 71 | 6 | 12693553 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.87e-04 | 582 | 71 | 7 | 20467437 | |
| Pubmed | Widespread macromolecular interaction perturbations in human genetic disorders. | 2.03e-04 | 590 | 71 | 7 | 25910212 | |
| Pubmed | 2.09e-04 | 142 | 71 | 4 | 30217970 | ||
| Pubmed | 2.23e-04 | 11 | 71 | 2 | 22844494 | ||
| Pubmed | 2.23e-04 | 11 | 71 | 2 | 23652018 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 2.38e-04 | 807 | 71 | 8 | 22681889 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 1.56e-03 | 19 | 56 | 2 | 832 | |
| GeneFamily | Ring finger proteins | 1.59e-03 | 275 | 56 | 5 | 58 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | 5.95e-06 | 481 | 71 | 9 | M3898 | |
| Coexpression | CYCLIN_D1_UP.V1_DN | 1.30e-05 | 190 | 71 | 6 | M2652 | |
| Coexpression | GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP | 1.55e-05 | 196 | 71 | 6 | M8135 | |
| Coexpression | GSE3982_MAC_VS_TH2_UP | 1.69e-05 | 199 | 71 | 6 | M5513 | |
| Coexpression | BOYAULT_LIVER_CANCER_SUBCLASS_G2 | 5.94e-05 | 28 | 71 | 3 | M10953 | |
| Coexpression | VALK_AML_CLUSTER_1 | 6.62e-05 | 29 | 71 | 3 | M19844 | |
| Coexpression | BENPORATH_ES_1 | 7.51e-05 | 379 | 71 | 7 | M1871 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 2.35e-08 | 191 | 71 | 7 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.11e-07 | 185 | 71 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-07 | 187 | 71 | 6 | 0ffb988e0da2c7205c3515eca8e9851739bff5c5 | |
| ToppCell | facs-Heart-Unknown|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-07 | 187 | 71 | 6 | 362e56426a568423a81e8a30e3ecf99b76135843 | |
| ToppCell | facs-Heart-Unknown-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-07 | 187 | 71 | 6 | c004567767b89f3d89f5c7b28d952f3445957e1e | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.62e-07 | 188 | 71 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 5.62e-07 | 188 | 71 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.62e-07 | 188 | 71 | 6 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.97e-07 | 190 | 71 | 6 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.55e-07 | 193 | 71 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 6.75e-07 | 194 | 71 | 6 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.95e-07 | 195 | 71 | 6 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.95e-07 | 195 | 71 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.16e-07 | 196 | 71 | 6 | ce6f7ddb8104471dc90347f427486379914d63b4 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.16e-07 | 196 | 71 | 6 | 6d7179decea512dd49bb2d5f6a4f5989349d52a9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.38e-07 | 197 | 71 | 6 | d16bb765afdc02406ffd7ce6a75bae72b66db66c | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.38e-07 | 197 | 71 | 6 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.38e-07 | 197 | 71 | 6 | 68c23c23b6924892f4c238cf2f5abc7927e04fbc | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 8.06e-07 | 200 | 71 | 6 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.48e-06 | 152 | 71 | 5 | 0cb5f4dfae04e3f4eba502bbf229007d5fa3884d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.48e-06 | 152 | 71 | 5 | ba89ffb5a8bb33c188f854f54b39123b6d73496a | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.63e-06 | 153 | 71 | 5 | ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.73e-06 | 170 | 71 | 5 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-06 | 172 | 71 | 5 | ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-06 | 172 | 71 | 5 | bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.41e-06 | 173 | 71 | 5 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.41e-06 | 173 | 71 | 5 | 5c55e1e27e9e3e77600d378cc87b51cc73907527 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.14e-06 | 176 | 71 | 5 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-06 | 176 | 71 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.40e-06 | 177 | 71 | 5 | 928118b0ed120ec01c7d753ce523ab609ac24e5f | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.40e-06 | 177 | 71 | 5 | dbdbdc8ed9ef0b529694242ef9f9f07a42e16005 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-05 | 181 | 71 | 5 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.10e-05 | 183 | 71 | 5 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.13e-05 | 184 | 71 | 5 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 186 | 71 | 5 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.23e-05 | 187 | 71 | 5 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 188 | 71 | 5 | 61f010c165826b434ca3d27553d4c9e13d2c0c51 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 188 | 71 | 5 | 7553ef7de3575af4cf34704b405b551c1af8eb83 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 189 | 71 | 5 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-05 | 189 | 71 | 5 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 189 | 71 | 5 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG/Astrocyte-7|World / Primary Cells by Cluster | 1.32e-05 | 190 | 71 | 5 | 8f1c490dd8e5f80382f5294fd1aa8cba4c3c647f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 190 | 71 | 5 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 190 | 71 | 5 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG/Astrocyte|World / Primary Cells by Cluster | 1.32e-05 | 190 | 71 | 5 | 7dbfd543398c63cbe1e68b54bcb5e2291f521935 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 191 | 71 | 5 | 8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-05 | 191 | 71 | 5 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 191 | 71 | 5 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 191 | 71 | 5 | 60bc1f3efa7bbad5cb7944fe5e049ea79cd1745a | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 191 | 71 | 5 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 192 | 71 | 5 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-05 | 193 | 71 | 5 | 5182284dfa7c94027e94172e08f78c86b95d63f4 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-05 | 193 | 71 | 5 | 4f7bab0115469c855160636d168bd6e5d4e2dd2f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 194 | 71 | 5 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.46e-05 | 194 | 71 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 194 | 71 | 5 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.50e-05 | 195 | 71 | 5 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.54e-05 | 196 | 71 | 5 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.58e-05 | 197 | 71 | 5 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-05 | 198 | 71 | 5 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-05 | 198 | 71 | 5 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-05 | 198 | 71 | 5 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-tDC|ICU-NoSEP / Disease, condition lineage and cell class | 1.65e-05 | 199 | 71 | 5 | 90ddd686b8f39c6f6134b9b048396cebcf8d0448 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.65e-05 | 199 | 71 | 5 | 2c5ad62919c64ea0242e0984bb9932d2d975f4e3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 199 | 71 | 5 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 200 | 71 | 5 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 200 | 71 | 5 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 200 | 71 | 5 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 200 | 71 | 5 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 200 | 71 | 5 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 200 | 71 | 5 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 200 | 71 | 5 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 200 | 71 | 5 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 200 | 71 | 5 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.69e-05 | 200 | 71 | 5 | 538ae964db58c4acafe93f735b3e03fc08fdaac6 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 200 | 71 | 5 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 200 | 71 | 5 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 200 | 71 | 5 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 200 | 71 | 5 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 4.34e-05 | 122 | 71 | 4 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.02e-05 | 138 | 71 | 4 | 5f8ac8f67e34a7cf560099208e6884102532391e | |
| ToppCell | AT1-AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 7.42e-05 | 140 | 71 | 4 | 45d52a086ced8d58e01ac51ac4a90338e8649b16 | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.63e-05 | 141 | 71 | 4 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | ileum-BEST4+_Enterocytes|ileum / shred on tissue and cell subclass | 1.07e-04 | 154 | 71 | 4 | 608e9c982125e0c2c15b86b1920813845a0db81f | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.18e-04 | 158 | 71 | 4 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.24e-04 | 160 | 71 | 4 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-04 | 160 | 71 | 4 | 8624f101828efd32cdd38a65df8d94d690720a63 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-04 | 160 | 71 | 4 | 9de3dd6b9d4b51314d60b3b01f4132bcfa2dfc18 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.27e-04 | 161 | 71 | 4 | b19f82dd98a3064581793711bb70373f18abecd9 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.30e-04 | 162 | 71 | 4 | 3f264263878af630921911c2b344ac56eb1e7099 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 165 | 71 | 4 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 165 | 71 | 4 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 166 | 71 | 4 | 13027ae342994db4540e64eb910df1f42b160931 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 166 | 71 | 4 | b21e45bd43f26149b9cd6e45c19241c82d54fb2f | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.47e-04 | 167 | 71 | 4 | dbd2b9f2f4ba7be5fdf8318094e6b078cb1d1c43 | |
| ToppCell | CTRL-Myeloid-Monocyte|CTRL / Disease state, Lineage and Cell class | 1.50e-04 | 168 | 71 | 4 | 13dca90c7b811e4d5e8fa44f5e892e29be9787a6 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.53e-04 | 169 | 71 | 4 | 16c52a0f6d96ecc1832922fce9b39691849f0d73 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.57e-04 | 170 | 71 | 4 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-04 | 170 | 71 | 4 | 4a19c7e3bb0f9c2601a10debe7000066789b4150 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.64e-04 | 172 | 71 | 4 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 6.50e-09 | 189 | 70 | 9 | 2797_DN | |
| Drug | Cefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 2.55e-06 | 198 | 70 | 7 | 3436_UP | |
| Drug | Suprofen [40828-46-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 2.55e-06 | 198 | 70 | 7 | 4005_DN | |
| Drug | Metformin hydrochloride [1115-70-4]; Up 200; 24.2uM; MCF7; HT_HG-U133A | 2.55e-06 | 198 | 70 | 7 | 1694_UP | |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.55e-05 | 189 | 70 | 6 | 5254_DN | |
| Drug | piperaquine | 2.79e-05 | 3 | 70 | 2 | CID000122262 | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; HL60; HT_HG-U133A | 2.87e-05 | 193 | 70 | 6 | 2332_DN | |
| Drug | (+,-)-Synephrine [94-07-5]; Down 200; 24uM; MCF7; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 6798_DN | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 5533_UP | |
| Drug | Hemicholinium bromide [312-45-8]; Down 200; 7uM; MCF7; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 3216_DN | |
| Drug | BAPTA-AM | 3.26e-05 | 293 | 70 | 7 | CID000002293 | |
| Drug | Trioxsalen [3902-71-4]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 6216_UP | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 3.50e-05 | 200 | 70 | 6 | 6034_DN | |
| Drug | Pirlindole mesylate [60762-57-4]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 3.50e-05 | 200 | 70 | 6 | 5497_UP | |
| Disease | obesity (implicated_via_orthology) | 1.35e-05 | 215 | 71 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | verbal-numerical reasoning measurement | 2.86e-04 | 131 | 71 | 4 | EFO_0008394 | |
| Disease | Colorectal Neoplasms | 5.52e-04 | 277 | 71 | 5 | C0009404 | |
| Disease | Colorectal Carcinoma | 1.49e-03 | 702 | 71 | 7 | C0009402 | |
| Disease | Vitiligo | 1.88e-03 | 101 | 71 | 3 | EFO_0004208 | |
| Disease | Hematopoetic Myelodysplasia | 2.22e-03 | 29 | 71 | 2 | C2713368 | |
| Disease | myelodysplastic syndrome (is_implicated_in) | 2.38e-03 | 30 | 71 | 2 | DOID:0050908 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VMDDQTQGSDPYIKM | 186 | Q9BT88 | |
| ITFQEQGDKMMEEYS | 1511 | O00555 | |
| PYGEMSNQEVMKSIE | 826 | P21709 | |
| VLMYDEIFMTEDPSK | 26 | Q5T2E6 | |
| PSLDTIKMQVYFDMN | 76 | Q8IYR0 | |
| TPMEVVDMLNDIYKS | 841 | P25092 | |
| YKIPIDNMTNEMEQR | 866 | Q9NVH2 | |
| ANYVVQKMIDMAEPA | 1001 | Q8TB72 | |
| QIPYEKNDEKMNEVM | 1221 | Q14571 | |
| MVVDDDSPEMYKTIS | 351 | Q0ZGT2 | |
| QEEMDTVMKDPYKVV | 96 | Q13823 | |
| DEYEMESPNITDTMK | 101 | P19256 | |
| GDPEVMQKMTDQVNY | 316 | Q13201 | |
| MDYLVTQIMDQKEGS | 701 | O60318 | |
| SKMDIPNTFQIDVMY | 181 | P35226 | |
| QIKVTMNDEDMDTYV | 246 | Q96A33 | |
| PNQEKVSDYEMKLMD | 106 | P12004 | |
| MMESTFPQQKDLDQV | 661 | Q14D04 | |
| QTFMEEMTRKQPDVD | 3051 | O94854 | |
| VIMMKENEYQASSVP | 691 | O15553 | |
| SESTVMPNMYDNVNK | 1066 | P23471 | |
| MEQLTKSPMEFVEYN | 626 | Q01970 | |
| EIPEEMTADETKDYM | 16 | Q6PIJ6 | |
| DKAQMPYTEATIMEV | 396 | Q7Z449 | |
| RMDEEFTKIMQNTDP | 451 | B5ME19 | |
| MEEPQKSYVNTMDLE | 1 | Q9NZS9 | |
| QLYEGKEQMEFEESM | 756 | Q92608 | |
| IDDMNMPEVDKYGTV | 2521 | Q9UFH2 | |
| KVLEDTGMPMDDDQY | 661 | Q5THR3 | |
| PEEYEMQMQKLNKDF | 206 | Q8NA03 | |
| MSNPRSLEEEKYDMS | 1 | P31944 | |
| TDEEMQYDMAKSGQE | 31 | Q8TAA1 | |
| MNNEYIVPMTEETKS | 1721 | Q92736 | |
| VKQMPFTEMSEENIT | 891 | P43246 | |
| TPEQISMDLKNELMY | 356 | Q08211 | |
| KDDESEVQIPMMYQQ | 206 | Q99574 | |
| VTMMQVEEKPDVTYS | 161 | P35998 | |
| MKSTKDYPDEVINFM | 421 | Q13275 | |
| IYMEPEKQVMSRSSD | 506 | Q9P2J5 | |
| KEFMNDPYIVITAME | 626 | Q587J7 | |
| KQVQPTMSQFEMDTY | 1716 | Q6ZNJ1 | |
| DVYDDVETIPMKNME | 826 | O43490 | |
| MDSDMDYERPNVETI | 1 | Q9BYZ6 | |
| KNFPMDMSDDYETQQ | 141 | P13521 | |
| PDQYQEDASDMKDMS | 51 | Q9BRV8 | |
| NTPMQLYSDDNIMET | 191 | Q53GG5 | |
| KMLEIYEPVSDSQMV | 211 | P13598 | |
| EAMKDMDSDQQYEKP | 41 | Q13023 | |
| FTISTLMDPEEMKDQ | 356 | Q6ZU45 | |
| MERIQNPEYSTTMDV | 146 | P48995 | |
| MEEPQMALYLQQAKE | 271 | Q9BYV2 | |
| EELELDPMAMTQKYE | 831 | Q13435 | |
| DPMAMTQKYEEHVRE | 836 | Q13435 | |
| EDSFQQIMNMKPYDL | 526 | O00308 | |
| TMKLAVMQAYDPEIN | 206 | O60858 | |
| EQRPVQMMYQEATFK | 191 | P50453 | |
| PKNEDEMMVAIFEYI | 71 | Q9H0D6 | |
| MEEKTDQPSDSEMMY | 1486 | Q9HCK1 | |
| VEPKTESYGDMNMEN | 246 | P48443 | |
| PEKYMMNSVLENFTI | 381 | Q15561 | |
| SKPYLTVDQMMDFIN | 236 | Q9NQ66 | |
| AQETYTCPKMIEMEQ | 21 | P57060 | |
| EKMVYMTVNDSQPED | 296 | P17010 | |
| RMESQLENVETPMSY | 466 | Q9BRR0 | |
| SDPEMTEEEKEYQMM | 321 | Q8TF01 | |
| SMIEQDVKRTFPEMQ | 161 | Q92609 | |
| MTQIVIMLYEDPNKD | 866 | O43314 | |
| DMEKLDEMEFNPVQQ | 56 | Q9Y2W2 | |
| MSQYTEKEPAAMDQE | 1 | O43164 | |
| YSVKEQEEMLLMSSP | 356 | P48549 | |
| SENMMIPDFKQQISE | 1206 | Q9NQX4 | |
| EKMLYEEETPKSQEM | 336 | O60237 |